- Details
- Description
Strength:
Larotrectinib INN 100 mg
Composition:
Larotrectinib INN 100 mg
Treatment:
NTRK gene fusion-positive solid tumors
Form:
Laronib
Brand:
Laronib 100
Manufacturer:
Everest Pharmaceuticals Ltd.
Laronib 100 is an oral targeted anticancer medicine containing Larotrectinib 100 mg, a selective TRK inhibitor. It is used for the treatment of solid tumors with NTRK gene fusions, where the tumor has the specific genetic alteration, under specialist medical supervision.
